Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].

Revista espanola de cardiologia - 1 Feb 2006

Rodríguez Esparragón Francisco, Hernández Trujillo Yaridé, Macías Reyes Antonio, Hernández Ortega Enrique, Medina Alfonso, Rodríguez Pérez José C

Abstract excerpt

High-density lipoprotein (HDL) is an independent protective factor against cardiovascular disease. The enzyme paraoxonase-1 (PON-1) contributes to the anti-atherogenic effects of HDL. In vitro studies have demonstrated that paraoxonase's substrates are highly heterogeneous and that some contribute to the development of atherosclerotic lesions. The atheroprotective role of PON-1 was established in genetically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Aryldialkylphosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol Esters

Share to Homocysteine

Share to Lipoproteins, HDL

Share to Lipoproteins, LDL

Share to Receptors, Lipoprotein

Share to Scavenger Receptors, Class B

Source

Identifiers

PMID: 16540037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].PMID 16540037Read ↗

Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.Semantic proximity Read ↗

Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations.Semantic proximity Read ↗

Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.Semantic proximity Read ↗

Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases.Semantic proximity Read ↗

Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.Semantic proximity Read ↗

The Molecular Bases of Anti-oxidative and Anti-inflammatory Properties of Paraoxonase 1Semantic proximity Read ↗

Paraoxonase 1 activity, concentration and genotype in cardiovascular diseaseSemantic proximity Read ↗

The paraoxonase 1, 2 and 3 in humans.Semantic proximity Read ↗

Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease RiskSemantic proximity Read ↗

Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.Semantic proximity Read ↗

Determinants of paraoxonase activity in healthy adults.Semantic proximity Read ↗

LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.